돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1692869생성일: 2026년 10월 25일

Diisopropylethylamine → 4-(1-((2-chloro-9-methyl-6-morpholino-9H-purin-8-yl)methyl)piperidin-4-yl)morpholine

https://huagongshe.com/reaction/1692869

반응식

참여 물질

역할이름HCID투입량
반응물DiisopropylethylamineHCID 81531—
반응물4-MorpholinopiperidineHCID 795724—
반응물4-(8-(bromomethyl)-2-chloro-9-methyl-9H-purin-6-yl)morpholineHCID 59603481—
용매DichloromethaneHCID 6344—
생성물4-(1-((2-chloro-9-methyl-6-morpholino-9H-purin-8-yl)methyl)piperidin-4-yl)morpholineHCID 5960349595%

반응 단계

To a solution of 4-(8-(bromomethyl)-2-chloro-9-methyl-9H-purin-6-yl)morpholine (935 mg, 2.7 mmol) in DCM (30 mL) was added 4-morpholino-piperidine (505 mg, 2.97 mmol) and DIEA (0.70 mL). The resulting mixture was stirred at room temperature for 18 hours. The mixture was then poured onto water and the layers were separated. The aqueous layer was extracted with three times with DCM. The combined organic extracts were washed with water, dried over Na2SO4, filtered and concentrated. The crude product was then purified by flash chromatography (0-30% gradient MeOH in DCM) to give the title compound as a white solid (95%). LCMS: M+H+=436.2.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08158625B2
출처 데이터셋uspto-grants-2012_04
ORD IDord-b862ae862dcf45b299df1ab5a96cd78c
출처 메모uspto-grants-2012_04